Sociedad Qu mica y Minera de Chile S.A. and GE Healthcare's Pharmaceutical Diagnostics business have announced a long-term agreement, to secure its supply of iodine, a key ingredient for contrast media products used in X-Ray and Computed Tomography (CT) procedures globally. The agreement will see SQM increase supply of iodine raw material year-on-year and is part of GE Healthcare's broader commitment and investment plan to enable the production of 30 million more patient doses of iodinated contrast media annually by 2025.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
48.01 USD | +0.10% | +5.08% | -20.28% |
24/04 | Tianqi Lithium Forecasts Loss in Q1 | MT |
24/04 | Tianqi Lithium Shares Dive After Warning of Wider Losses | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.28% | 13.7B | |
+17.43% | 65.38B | |
+0.11% | 47.8B | |
+16.88% | 40.65B | |
+22.79% | 26.69B | |
+12.85% | 19.24B | |
+4.74% | 17.75B | |
-22.01% | 16B | |
-8.95% | 15.37B | |
+3.47% | 15.23B |
- Stock Market
- Equities
- SQM Stock
- News Sociedad Química y Minera de Chile S.A.
- Sociedad Química Y Minera De Chile S.A. Announces Long-Term Agreement